Related references
Note: Only part of the references are listed.PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice
Vicente Villanueva et al.
JOURNAL OF NEUROLOGY (2022)
Does a psychiatric history play a role in the development of psychiatric adverse events to perampanel. .. and to placebo?
Andres M. Kanner et al.
EPILEPSY & BEHAVIOR (2021)
An evaluation of the effectiveness of perampanel in people with epilepsy who have previously undergone resective surgery and/or implantation of a vagal nerve stimulator
Gabriel Davis Jones et al.
EPILEPSY & BEHAVIOR (2021)
Comparative 12-month retention rate, effectiveness and tolerability of perampanel when used as a first add-on or a late add-on treatment in patients with focal epilepsies: The COM-PER study
Nuno Canas et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)
Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL study
X. Rodriguez-Osorio et al.
EPILEPSY RESEARCH (2021)
Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures
Andras Fogarasi et al.
EPILEPSIA (2020)
Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies
J. Eric Pina-Garza et al.
EPILEPSY & BEHAVIOR (2020)
Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)
Javier Abril Jaramillo et al.
EPILEPSY & BEHAVIOR (2020)
Electro-clinical analysis of epilepsy patients with generalized seizures on adjunctive perampanel treatment
Francisco Javier Montoya Gutierrez et al.
EPILEPSY RESEARCH (2020)
Comparison of the effectiveness and tolerability of perampanel and brivaracetam: a real-world, observational, retrospective study
Claudio Liguori et al.
EPILEPTIC DISORDERS (2020)
Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)
Antonietta Coppola et al.
FRONTIERS IN NEUROLOGY (2020)
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a real world context: focus on temporal lobe epilepsy
Angelo Pascarella et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization
Eugen Trinka et al.
EPILEPSY RESEARCH (2020)
Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs
Estevo Santamarina et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study
Manuela Contin et al.
EPILEPSY & BEHAVIOR (2020)
Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy
Masashi Chonan et al.
NEUROLOGIA MEDICO-CHIRURGICA (2020)
Adjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy
J. Ben Renfroe et al.
JOURNAL OF CHILD NEUROLOGY (2019)
The effect of perampanel on aggression and depression in patients with epilepsy: A short-term prospective study
Hiroko Goji et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
Plasma concentration and clinical effects of perampanel-The Kork experience
Bernhard J. Steinhoff et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
The impact of perampanel treatment on quality of life and psychiatric symptoms in patients with drug-resistant focal epilepsy: An observational study in Italy
Francesco Deleo et al.
EPILEPSY & BEHAVIOR (2019)
Seizures in glioma patients: An overview of incidence, etiology, and therapies
Niyatee Samudra et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis
Marta Maschio et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2019)
Seizures and Tumor Progression in Glioma Patients with Uncontrollable Epilepsy Treated with Perampanel
Shuichi Izumoto et al.
ANTICANCER RESEARCH (2018)
Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study
Claudio Liguori et al.
EPILEPSY & BEHAVIOR (2018)
Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre
Alessandra Morano et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Adjunctive perampanel for glioma-associated epilepsy
Anastasie M. Dunn-Pirio et al.
EPILEPSY & BEHAVIOR CASE REPORTS (2018)
Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study
Vicente Villanueva et al.
EPILEPSIA (2018)
Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data
Alexandra Rohracher et al.
EPILEPSIA (2018)
Retention of perampanel in adults with pharmacoresistant epilepsy at a single tertiary care center
Tim Wehner et al.
EPILEPSY & BEHAVIOR (2017)
Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations
Charles Vecht et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Perampanel in the general population and in people with intellectual disability: Differing responses
Rohit Shankar et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center
Christoph Kurth et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Prospective audit with adjunctive perampanel: Preliminary observations in focal epilepsy
Martin J. Brodie et al.
EPILEPSY & BEHAVIOR (2016)
Adjunctive perampanel in refractory epilepsy: Experience at tertiary epilepsy care center in Tours
Aude Maurousset et al.
EPILEPSY & BEHAVIOR (2016)
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study
V. Villanueva et al.
EPILEPSY RESEARCH (2016)
Pharmacokinetics, exposure-cognition, and exposure-efficacy relationships of perampanel in adolescents with in adequately controlled partial-onset seizures
Vicente Villanueva et al.
EPILEPSY RESEARCH (2016)
The New Antiepileptic Drugs: Their Neuropharmacology and Clinical Indications
Ryosuke Hanaya et al.
NEUROLOGIA MEDICO-CHIRURGICA (2016)
Clinical experience with adjunctive perampanel in adult patients with uncontrolled epilepsy: A UK and Ireland multicentre study
Emily Shah et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2016)
Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data
Alexandra Rohracher et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
One-year clinical experience of perampanel in Spain: a multicentre study of efficacy and tolerability
Inigo Garamendi-Ruiz et al.
EPILEPTIC DISORDERS (2016)
Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel
Alan B. Ettinger et al.
EPILEPSIA (2015)
Perampanel in the treatment of partial seizures: Time to onset and duration of most common adverse events from pooled Phase III and extension studies
David Ko et al.
EPILEPSY & BEHAVIOR (2015)
Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial
Jacqueline A. French et al.
NEUROLOGY (2015)
Perampanel for adjunctive treatment of partial- onset seizures: A pooled dose- response analysis of phase III studies
Lynn D. Kramer et al.
EPILEPSIA (2014)
The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis
Nasreen Khan et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305
Jacqueline A. French et al.
EPILEPSIA (2013)
Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies
Bernhard J. Steinhoff et al.
EPILEPSIA (2013)
Optimizing antiepileptic drug treatment in tumoral epilepsy
Emilio Perucca
EPILEPSIA (2013)
Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures
Barry E. Gidal et al.
EPILEPSIA (2013)
Adjunctive perampanel for refractory partial-onset seizures Randomized phase III study 304
Jacqueline A. French et al.
NEUROLOGY (2012)
Randomized phase III study 306 Adjunctive perampanel for refractory partial-onset seizures
G. L. Krauss et al.
NEUROLOGY (2012)
Proactive Compared With Passive Adverse Event Recognition: Calcium Channel Blocker-Associated Edema
Steven G. Chrysant
JOURNAL OF CLINICAL HYPERTENSION (2008)
Patient reporting of potential adverse drug reactions: a methodological study
N Jarernsiripornkul et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Randomized, controlled trials, observational studies, and the hierarchy of research designs.
J Concato et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
